CMS Open Payments · Program Year 2024
Inquis Medical, Inc.
Inquis Medical, Inc. reported $626,564.87 across General Payments, Research, and Ownership to 132 physicians and teaching hospitals across 135 transactions.
- $626.6K Above-median payer
- All-tracks total
- 135 Below-median volume
- Transactions
- 132 Below-median reach
- Recipients
- #717
- of 1,925 companies
Inquis Medical, Inc. reported $626,564.87 across all CMS Open Payments tracks (General + Research + Ownership) to 132 physicians and teaching hospitals in Program Year 2024 - ranking #717 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $57,981.87, averaging $4.7K per recipient.
How Inquis Medical, Inc.'s $626.6K all-tracks total breaks down
Inquis Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
16/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer inquis-medical-inc Inquis Medical, Inc.
$626.6K · #717/1,925 · 0.0% industry · PY2024
- TOT $626.6K
- RANK #717
- SHARE 0.0%
- TXN 135
- RCP 132
- CAT 4
- GEN $58.0K
- TOP1 40.5%
- PY 2024
Volume peers
Nearest volume peer: Roche Diagnostics International Ltd ($627.8K)
Inquis Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Inquis Medical, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Inquis Medical, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $48.0K across 24 transactions, 82.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Inquis Medical, Inc. made 4 types of general payments. "Consulting Fee" is the largest category at $48.0K, 82.9% of General Payments.
Inquis Medical, Inc. reports 4 general-payment categories - the top three are Consulting Fee (82.9%), Food and Beverage (10.1%), and Grant (5.2%). The remaining 1 category make up 1.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Inquis Medical, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $48.0K | 24 | 82.9% |
| Food and Beverage | $5.9K | 104 | 10.1% |
| Grant | $3.0K | 1 | 5.2% |
| Travel and Lodging | $1.0K | 3 | 1.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $45,510.72 (78.5%) of $57,981.87 in this company's General Payments records across 69 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Inquis Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Mehdi Shishehbor
$23,456.43 across 13 reported transactions
- 2
Samuel Horr
$7,280.31 across 7 reported transactions
- 3
Brian Stegman
$6,640.65 across 8 reported transactions
- 4
Christopher Huff
$5,133.33 across 2 reported transactions
- 5
Uh Cleveland Medical Center
$3,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Inquis Medical, Inc.'s spend rank (#717 of 1,925, top 37% by spend) and concentration rank (#736 of 1,838, top 40% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Tosoh Bioscience, Inc. : $290.85 total payments, HHI 2118
- Meridian Bioscience Inc. : $173.7K total payments, HHI 2110
- Alaska Medical Technologies, Llc : $3.2K total payments, HHI 2108
- Ortho-Clinical Diagnostics, Inc. : $1.1M total payments, HHI 2099
- Endeavor Orthopaedics LLC : $427.85 total payments, HHI 2098
- MediView XR, Inc. : $31.1K total payments, HHI 2083
- Inquis Medical, Inc. (this company) : $58.0K total payments, HHI 2081
- Nexus Spine, LLC : $35.1K total payments, HHI 2077
- Integer Holdings Corporation : $54.0K total payments, HHI 2076
- Central California Surgical Distributors, LLC : $321.5K total payments, HHI 2076
- Circa Scientific, Inc. : $16.3K total payments, HHI 2069
- Forthright Medical-AZ, LLC : $24.8K total payments, HHI 2052
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Inquis Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Inquis Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Inquis Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
EvoEndo, Inc
Distalmotion US
Biofrontera Inc.
Bone Support Inc.
Edap Technomed Inc
Put this to use
Inquis Medical, Inc. ranks #717 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Inquis Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.